HOME >> MEDICINE >> NEWS
Botox helps ease symptoms of enlarged prostate according to Univ. of Pittsburgh study

SAN FRANCISCO, May 11 Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan. Results will be presented today at the annual meeting of the American Urological Association (AUA) in San Francisco and published in abstract 1524 in the AUA proceedings.

"For most men, enlarged prostate is considered to be an uncomfortable inevitability of aging," said Michael Chancellor, M.D., professor of urology and gynecology at the University of Pittsburgh School of Medicine. "Common treatments can have serious side effects, including impotence. We have completed a number of studies that have shown botox injections are a safe and effective treatment for conditions of the lower urinary tract; in this study, we have shown the same may be true for using botox injections for enlarged prostate."

Eleven patients, ranging in age from 50 to 82 years, who had symptomatic BPH that did not respond to alpha-blocker treatment, received injections of botox into their prostate. Three to seven days post-injection the patients showed a decrease in irritative symptoms as indicated by a reduction in the international prostate symptom score by 62.3 percent and improvement in the quality of life index by 56.5 percent. Patients also experienced a significant increase in flow rate, and a small decrease in residual urine and prostate size.

Patients did not experience any significant side effects including stress urinary incontinence, retrograde ejaculation or erectile dysfunction.

BPH is one of the most common diseases affecting men. More than half of all men over the age of 60, and 80 percent by age 80, will have enlarged prostates. Forty to 50 percent will develop symptoms of BPH, which
'"/>

Contact: Jocelyn Uhl
UhlJH@upmc.edu
412-647-3555
University of Pittsburgh Medical Center
11-May-2004


Page: 1 2

Related medicine news :

1. Botox could play a key role in pain control during breast reconstruction
2. Researchers at Wake Forest University Baptist use Botox to treat CP
3. Botox injections restore voices, confidence to voice disorder patients
4. Botox proving successful at preventing headaches
5. Botox Treats Excessive Sweating, According To UCSF Study
6. Protein that helps skin cancer spread identified by Stanford researchers
7. Treating depression helps slow physical decline in older adults, study shows
8. Laughter helps blood vessels function better
9. Chemists synthesize molecule that helps body battle cancers, malaria
10. Medication helps alcoholics control drinking
11. Changing chemistry helps explain estrogen threat to the heart

Post Your Comments:
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Compare-autoinsurance.org has released a ... insured by an auto insurance policy . , Some ... policy. Clients should check the newly released blog post to see ... cars and dangerously damaged vehicles are some of the cars that ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
Breaking Medicine News(10 mins):Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: